Psoriasis Clinical Trial

Clinical Trial Finder Psoriasis Trials

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

See Locations Near You

Summary

This study assessed efficacy of secukinumab, compared to ustekinumab, in patients that have plaque-type psoriasis

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

patients with moderate to severe plaque type psoriasis for at least 6 months before randomization
patients eligible for systemic therapy with inadequately controlled psoriasis

Exclusion Criteria:

forms of sporiasis other than plaque type psoriasis
previous exposure to secukinumab, ustekinumab, or other biologic drugs targeting (IL)-17A or IL-17RA

Other protocol-defined inclusion/exclusion criteria may apply

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

676

Study ID:

NCT02074982

Recruitment Status:

Completed

Sponsor:

Novartis Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 136 Locations for this study

See Locations Near You

Novartis Investigative Site
Birmingham Alabama, 35205, United States
Novartis Investigative Site
Mobile Alabama, 36608, United States
Novartis Investigative Site
Phoenix Arizona, 85032, United States
Novartis Investigative Site
Hot Springs Arkansas, 71913, United States
Novartis Investigative Site
Los Angeles California, 90045, United States
Novartis Investigative Site
Oceanside California, 92056, United States
Novartis Investigative Site
Santa Monica California, 90404, United States
Novartis Investigative Site
South Miami Florida, 33143, United States
Novartis Investigative Site
Arlington Heights Illinois, 60005, United States
Novartis Investigative Site
Champaign Illinois, 61820, United States
Novartis Investigative Site
Skokie Illinois, 60077, United States
Novartis Investigative Site
Indianapolis Indiana, 46256, United States
Novartis Investigative Site
Overland Park Kansas, 66215, United States
Novartis Investigative Site
Owensboro Kentucky, 42301, United States
Novartis Investigative Site
Boston Massachusetts, 02111, United States
Novartis Investigative Site
Saint Louis Missouri, 63117, United States
Novartis Investigative Site
East Windsor New Jersey, 08520, United States
Novartis Investigative Site
Forest Hills New York, 11375, United States
Novartis Investigative Site
Portland Oregon, 97210, United States
Novartis Investigative Site
Portland Oregon, 97223, United States
Novartis Investigative Site
Greer South Carolina, 29651, United States
Novartis Investigative Site
Dallas Texas, 75230, United States
Novartis Investigative Site
Houston Texas, 77030, United States
Novartis Investigative Site
San Antonio Texas, 78229, United States
Novartis Investigative Site
Norfolk Virginia, 23507, United States
Novartis Investigative Site
Seattle Washington, 98101, United States
Novartis Investigative Site
Phillip Australian Capital Territory, 2606, Australia
Novartis Investigative Site
Sydney New South Wales, 2010, Australia
Novartis Investigative Site
Woolloongabba Queensland, 4102, Australia
Novartis Investigative Site
East Melbourne Victoria, 3002, Australia
Novartis Investigative Site
Innsbruck , 6020, Austria
Novartis Investigative Site
Linz , A-402, Austria
Novartis Investigative Site
Vienna , A-103, Austria
Novartis Investigative Site
Wien , A-109, Austria
Novartis Investigative Site
Gent , 9000, Belgium
Novartis Investigative Site
Liege , 4000, Belgium
Novartis Investigative Site
Namur , 5000, Belgium
Novartis Investigative Site
Pleven , 5800, Bulgaria
Novartis Investigative Site
Sofia , 1404, Bulgaria
Novartis Investigative Site
Sofia , 1431, Bulgaria
Novartis Investigative Site
Varna , 9000, Bulgaria
Novartis Investigative Site
Etobicoke Ontario, M8X 1, Canada
Novartis Investigative Site
Hamilton Ontario, L8N 1, Canada
Novartis Investigative Site
Mississauga Ontario, L5H 1, Canada
Novartis Investigative Site
Sainte-Foy Quebec, G1V 4, Canada
Novartis Investigative Site
Arhus C , DK-80, Denmark
Novartis Investigative Site
Tallinn , 10138, Estonia
Novartis Investigative Site
Tartu , 51014, Estonia
Novartis Investigative Site
Bordeaux , 33076, France
Novartis Investigative Site
Brest , 29609, France
Novartis Investigative Site
La Rochelle , 17019, France
Novartis Investigative Site
Martigues , 13500, France
Novartis Investigative Site
Nice Cedex 3 , 06202, France
Novartis Investigative Site
Augsburg , 86179, Germany
Novartis Investigative Site
Bad Bentheim , 48455, Germany
Novartis Investigative Site
Berlin , 10783, Germany
Novartis Investigative Site
Berlin , 13187, Germany
Novartis Investigative Site
Berlin , 13507, Germany
Novartis Investigative Site
Bielefeld , 33647, Germany
Novartis Investigative Site
Bochum , 44803, Germany
Novartis Investigative Site
Darmstadt , 64283, Germany
Novartis Investigative Site
Dessau-Rosslau , 06847, Germany
Novartis Investigative Site
Dresden , 01307, Germany
Novartis Investigative Site
Erlangen , 91054, Germany
Novartis Investigative Site
Frankfurt , 60590, Germany
Novartis Investigative Site
Hamburg , 20354, Germany
Novartis Investigative Site
Hamburg , 22391, Germany
Novartis Investigative Site
Kiel , 24105, Germany
Novartis Investigative Site
Kiel , 24148, Germany
Novartis Investigative Site
Lubeck , 23538, Germany
Novartis Investigative Site
Ludwigshafen , 67063, Germany
Novartis Investigative Site
Mainz , 55131, Germany
Novartis Investigative Site
Muenster , 48149, Germany
Novartis Investigative Site
Münster , 48159, Germany
Novartis Investigative Site
Pommelsbrunn , 91224, Germany
Novartis Investigative Site
Heraklion, Crete GR, 71110, Greece
Novartis Investigative Site
Budapest , 1134, Hungary
Novartis Investigative Site
Szeged , H-672, Hungary
Novartis Investigative Site
Afula , 18341, Israel
Novartis Investigative Site
Petach Tikva , 49100, Israel
Novartis Investigative Site
Tel Aviv , 62098, Israel
Novartis Investigative Site
Tel Aviv , 64239, Israel
Novartis Investigative Site
Bologna BO, 40138, Italy
Novartis Investigative Site
Modena MO, 41100, Italy
Novartis Investigative Site
Verona VR, 37126, Italy
Novartis Investigative Site
Seoul Korea, 03722, Korea, Republic of
Novartis Investigative Site
Seoul Korea, 06351, Korea, Republic of
Novartis Investigative Site
Gwangju , 501-7, Korea, Republic of
Novartis Investigative Site
Breda CK, 4818, Netherlands
Novartis Investigative Site
Nijmegen , 6500 , Netherlands
Novartis Investigative Site
Rotterdam , 3015 , Netherlands
Novartis Investigative Site
Sneek , 8601 , Netherlands
Novartis Investigative Site
Zwijndrecht , 3331 , Netherlands
Novartis Investigative Site
Bergen , NO-50, Norway
Novartis Investigative Site
Coimbra , 3000-, Portugal
Novartis Investigative Site
Lisboa , 1649-, Portugal
Novartis Investigative Site
Lisbon , 1069-, Portugal
Novartis Investigative Site
Porto , 4099-, Portugal
Novartis Investigative Site
Porto , 4200-, Portugal
Novartis Investigative Site
Banska Bystrica Slovak Republic, 97401, Slovakia
Novartis Investigative Site
Kosice-Saca Slovak republic, 040 1, Slovakia
Novartis Investigative Site
Bojnice , 972 0, Slovakia
Novartis Investigative Site
Kosice , 04001, Slovakia
Novartis Investigative Site
Granada Andalucia, 18012, Spain
Novartis Investigative Site
Malaga Andalucia, 29010, Spain
Novartis Investigative Site
Oviedo Asturias, 33011, Spain
Novartis Investigative Site
Hospitalet de Llobregat Barcelona, 08907, Spain
Novartis Investigative Site
Badalona Catalunya, 08916, Spain
Novartis Investigative Site
Barcelona Catalunya, 08003, Spain
Novartis Investigative Site
Barcelona Catalunya, 08036, Spain
Novartis Investigative Site
Alicante Comunidad Valenciana, 03010, Spain
Novartis Investigative Site
Valencia Comunidad Valenciana, 46014, Spain
Novartis Investigative Site
Valencia Comunidad Valenciana, 46026, Spain
Novartis Investigative Site
Las Palmas de Gran Canaria Las Palmas de G.C, 35010, Spain
Novartis Investigative Site
Alcorcon Madrid, 28922, Spain
Novartis Investigative Site
Majadahonda Madrid, 28222, Spain
Novartis Investigative Site
Bilbao Pais Vasco, 48013, Spain
Novartis Investigative Site
San Sebastian Pais Vasco, 20080, Spain
Novartis Investigative Site
Barcelona , 08041, Spain
Novartis Investigative Site
Madrid , 28006, Spain
Novartis Investigative Site
Madrid , 28007, Spain
Novartis Investigative Site
Madrid , 28031, Spain
Novartis Investigative Site
Madrid , 28041, Spain
Novartis Investigative Site
Madrid , 28046, Spain
Novartis Investigative Site
Lausanne , 1011, Switzerland
Novartis Investigative Site
Lin-Kou , 33305, Taiwan
Novartis Investigative Site
Taipei , 10002, Taiwan
Novartis Investigative Site
Balcova / Izmir , 35340, Turkey
Novartis Investigative Site
Bursa , 16059, Turkey
Novartis Investigative Site
Salford Manchester, M6 8H, United Kingdom
Novartis Investigative Site
Dundee Perthshire, DD1 9, United Kingdom
Novartis Investigative Site
Redhill Surrey, RH1 5, United Kingdom
Novartis Investigative Site
Bradford West Yorkshire, BD5 0, United Kingdom
Novartis Investigative Site
Coventry , CV2 2, United Kingdom
Novartis Investigative Site
Harrogate , HG2 7, United Kingdom
Novartis Investigative Site
Hull , HU3 2, United Kingdom
Novartis Investigative Site
Stoke-on-Trent , ST4 6, United Kingdom
Load More

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

676

Study ID:

NCT02074982

Recruitment Status:

Completed

Sponsor:


Novartis Pharmaceuticals

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider